CARsgen Therapeutics Competitors and Similar CompaniesClear all

CARsgen Therapeutics's competitors and similar companies include OncoTherapy Science, Numab and Calidi Biotherapeutics.
CARsgen Therapeutics
CARsgen Therapeutics
CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.
OncoTherapy Science
OncoTherapy Science
OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
Numab
Numab
Numab Therapeutics is an oncology-focused biopharmaceutical company.
Calidi Biotherapeutics
Calidi Biotherapeutics
Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer.
Founding Date
Founding Date
2014
Founding Date
2001
Founding Date
2011
Founding Date
2014
Type
Type
Private
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Shanghai, CN HQ
Beijing, CN
Shanghai, CN
Shanghai, CN
Bellaire, US
Locations
Kawasaki, JP HQ
Locations
Wädenswil, CH HQ
Locations
San Diego, US HQ
Bernried, DE
Employees
Employees
100
Employees
54
Employees
681% decrease
Employees
327% increase

Funding

Latest funding round
Latest funding round
$ 186m (over 5 years ago)
Latest funding round
N/A
Latest funding round
$ 110m (about 5 years ago)
Latest funding round
$ 8.2m (over 6 years ago)
Total funding raised
Total funding raised
$ 276m
Total funding raised
N/A
Total funding raised
$ 132.3m
Total funding raised
$ 20m
For sources of this data, please see the company profile

View Company Profiles

OncoTherapy Science
HQ
Kawasaki, JP
Employees
54

OncoTherapy Science is a company engaged in research and development of cancer therapeutics.

View company
Numab
HQ
Wädenswil, CH
Employees
68↓ 1% decrease

Numab Therapeutics is an oncology-focused biopharmaceutical company.

View company
Calidi Biotherapeutics
HQ
San Diego, US
Employees
32↑ 7% increase

Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer.

View company